Skip to content

Resolute Integrity™ RSINT25030WRecalls & reported problems

Medtronic, Inc. · Stent RSINT25030W MicroTrac 2.50X30OTW · Class 3 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00613994793270), received between Apr 7, 2017 and Apr 7, 2017 — classified as 1 malfunction.

The most frequently reported specific device problem is “Material Deformation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Material Deformation1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 7, 2017Material Deformation; Material Deformation

    IT IS REPORTED THAT DURING USE, THE RESOLUTE INTEGRITY DRUG-ELUTING STENT (DES) BECAME DAMAGED WHEN TRYING TO PLACE IT IN THE DIAGONAL VESSEL. DEVICE WAS INSPECTED PRIOR TO USE , NO ISSUES NOTED. LESION WAS PRE-DILATED. RESISTANCE WAS NOTED WHEN ADVANCING THE DEVICE AND EXCESSIVE FORCE WAS USED. THE PROCEDURE WAS COMPLETED WITH ANOTHER RESOLUTE DES AFTER ANCHORING A BALLOON IN THE LAD. THE BALLOON ENABLED THE NEW STENT TO CROSS THE LESION.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6471190 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page